Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease
NCT06775964Phase 2Recruiting
- Sponsor
- Paul E. Schulz
- Start
- Mar 2026
- Primary completion
- Jan 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in Alzheimer's disease (AD), sponsored by Paul E. Schulz. Started Mar 2026; status: recruiting.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06775964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06775964.